BiotechTube
Home/BioCity Biopharma/Ivy Wang, MD, PhD
IW

Ivy Wang, MD, PhD

Co-founder, Executive President & Chief Strategy Officer

BioCity Biopharma

Therapeutic Areas

OncologyImmunology

BioCity Biopharma Pipeline

DrugIndicationPhase
SC0062Diabetic Kidney Disease (DKD) with AlbuminuriaPhase 2
BC3195Locally Advanced or Metastatic Solid TumorsPhase 1
BC3402 + IMFINZIHepatocellular Carcinoma (HCC)Phase 1b/2
BC3448Not Specified (Oncology)Phase 1
BC2027Not Specified (Oncology)Phase 1
SC0191Ovarian CancerPhase 1/2
SC0245Small Cell Lung Cancer (SCLC)Phase 1

Leadership Team at BioCity Biopharma

XB
Xiang Bo Jia
Founder, Chairman & CEO
DE
Dr. Eric Rowinsky
US Chief Medical Officer (CMO)
DL
Dr. Leah DiMascio
US Clinical Operation Head
View full BioCity Biopharma profile